DV Biomed Co., Ltd. (6539) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for DV Biomed Co., Ltd. (6539:TWSE), powered by AI.

Current Price
$40.95
Sector
Healthcare
What is the DV Biomed Co., Ltd. stock price forecast?

DV Biomed Co., Ltd. is currently trading at $40.95. View real-time AI analysis on Alpha Lenz.

What is DV Biomed Co., Ltd. insider trading activity?

View the latest insider trading data for DV Biomed Co., Ltd. on Alpha Lenz.

What is DV Biomed Co., Ltd.'s P/E ratio?

View DV Biomed Co., Ltd.'s valuation metrics on Alpha Lenz.

DV Biomed Co., Ltd.

TWSE · 6539
NT$40.95-0.05(-0.12%)
Ask about DV Biomed Co., Ltd.'s future dividend policy...
Alpha Chat Insight

DV Biomed Co., Ltd.'s ROE is 1.5%. Explore profitability and growth together.

Ask for details

Company Overview

DV Biomed Co., Ltd. is a biotechnology and healthcare company specializing in the manufacture and distribution of medical-grade skin care products and health-related solutions. Founded in 2011 and headquartered in Taipei, the company operates primarily in the healthcare and biotechnology sectors, with activities extending across Taiwan and China. DV Biomed’s offerings encompass a range of skin care products, health and slimming services, and medical aesthetic fillers, along with aesthetic medical equipment for use in medical beauty industries. The company is also involved in the research and development of stem cell technologies, genomics, anti-cancer drugs, and proteomics, reflecting a commitment to innovative therapies and advanced health solutions. In addition to these specialized products and services, DV Biomed provides functional beverages and nutritional supplements targeting beauty, wellness, and slimming markets. With a diverse portfolio spanning medical consumables, beauty equipment rentals, and services in both clinical and consumer spheres, DV Biomed Co., Ltd. plays a significant role in supporting health, wellness, and cosmetic advancements throughout the region.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$794.18MRevenue
0.00Shares Out
0Employees

Margins

71.35%Gross
5.93%EBITDA
1.88%Operating
1.27%Pre-Tax
0.97%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-24.78%Rev 3Yr
-15.21%Rev 5Yr
-66.21%Op Inc 3Yr
-43.96%Op Inc 5Yr
-69.81%Net Inc 3Yr
-51.38%Net Inc 5Yr

Returns

1.06%ROA
1.49%ROE
1.60%ROIC

Financial Health

NT$113.96MCash & Cash Equivalents
NT$55.85MNet Debt
33.47%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

DV Biomed Co., Ltd. (ticker: 6539) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).

The current price is 40.95 with a P/E ratio of -x and P/B of -x.

ROE is 1.49% and operating margin is 1.88%. Annual revenue is $794M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
DV Biomed Co., Ltd. (6539) Stock Forecast 2026 $40.95 — Price, Financials & Analyst Targets | Alpha Lenz